Epiminder Limited (ASX:EPI)
Australia · Delayed Price · Currency is AUD 0.5800
-0.0400 (-6.45%)
Last updated: Apr 28, 2026, 3:05 PM AEST
Epiminder Market Cap
Epiminder has a market cap or net worth of 134.14 million as of April 28, 2026.
Market Cap
134.14M
Enterprise Value
44.64M
Revenue
648.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.58
Market Cap Chart
Since December 1, 2025, Epiminder's market cap has decreased from 283.42M to 134.14M, a decrease of -52.67%. That is a compound annual growth rate of -84.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 134.14M | -39.22% |
| Dec 31, 2025 | 220.68M | -22.14% |
| Dec 1, 2025 | 283.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 186.79M |
| EMVision Medical Devices | 161.71M |
| Lumos Diagnostics Holdings | 147.63M |
| SomnoMed | 135.83M |
| Cleo Diagnostics | 85.54M |
| Compumedics | 59.93M |
| HeraMED | 55.44M |
| Micro-X | 42.15M |